These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27749131)

  • 1. PREDICTORS OF QUALITY OF LIFE IN 165 PATIENTS WITH ACROMEGALY: RESULTS FROM A SINGLE-CENTER STUDY.
    Kreitschmann-Andermahr I; Buchfelder M; Kleist B; Kohlmann J; Menzel C; Buslei R; Kołtowska-Häggsträm M; Strasburger C; Siegel S
    Endocr Pract; 2017 Jan; 23(1):79-88. PubMed ID: 27749131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between treatment and systemic inflammation in acromegaly.
    Wolters TLC; van der Heijden CDCC; Pinzariu O; Hijmans-Kersten BTP; Jacobs C; Kaffa C; Hoischen A; Netea MG; Smit JWA; Thijssen DHJ; Georgescu CE; Riksen NP; Netea-Maier RT
    Growth Horm IGF Res; 2021; 57-58():101391. PubMed ID: 33964727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of acromegaly: the patient's perspective.
    Kreitschmann-Andermahr I; Siegel S; Kleist B; Kohlmann J; Starz D; Buslei R; Koltowska-Häggström M; Strasburger CJ; Buchfelder M
    Pituitary; 2016 Jun; 19(3):268-76. PubMed ID: 26742496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current diagnosis and treatment of acromegaly].
    Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
    Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.
    Gheorghiu ML; Găloiu S; Vintilă M; Purice M; Hortopan D; Dumitraşcu A; Coculescu M; Poiană C
    Hormones (Athens); 2016 Apr; 15(2):224-234. PubMed ID: 27376425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A registry of acromegaly patients and one year following up in Taiwan.
    Tseng FY; Huang TS; Lin JD; Chen ST; Wang PW; Chen JF; Huey-Herng Sheu W; Chang TC;
    J Formos Med Assoc; 2019 Oct; 118(10):1430-1437. PubMed ID: 30612883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in quality of life in patients with acromegaly after surgical remission - A prospective study using SF-36 questionnaire.
    Fujio S; Arimura H; Hirano H; Habu M; Bohara M; Moinuddin FM; Kinoshita Y; Arita K
    Endocr J; 2017 Jan; 64(1):27-38. PubMed ID: 27681883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and treatment outcomes of pegvisomant in Japanese patients with acromegaly: results from the post-marketing surveillance.
    Yamaguchi H; Shimatsu A; Okayama A; Sato T
    Endocr J; 2020 Feb; 67(2):201-210. PubMed ID: 31723069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database.
    Matsubayashi K; Kawakami K
    Endocr J; 2020 Oct; 67(10):997-1006. PubMed ID: 32522909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life Changes Before and After Transsphenoidal Surgery for Sellar and Parasellar Lesions.
    Ishikawa T; Takeuchi K; Nagatani T; Aimi Y; Tanemura E; Tambara M; Nagata Y; Choo J; Wakabayashi T
    World Neurosurg; 2019 Feb; 122():e1202-e1210. PubMed ID: 30447458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acromegaly improves quality of life, measured by AcroQol.
    Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of current and emerging treatment options in acromegaly.
    Muhammad A; van der Lely AJ; Neggers SJ
    Neth J Med; 2015 Oct; 73(8):362-7. PubMed ID: 26478545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the treatment of acromegaly].
    Krysiak R; Okopień B; Marek B
    Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LIMITATIONS OF CURRENT APPROACHES FOR THE TREATMENT OF ACROMEGALY.
    Shanik MH
    Endocr Pract; 2016 Feb; 22(2):210-9. PubMed ID: 26437214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.
    Postma MR; Netea-Maier RT; van den Berg G; Homan J; Sluiter WJ; Wagenmakers MA; van den Bergh AC; Wolffenbuttel BH; Hermus AR; van Beek AP
    Eur J Endocrinol; 2012 Apr; 166(4):585-92. PubMed ID: 22250074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of medical treatment in patients with acromegaly in clinical practice.
    Lee SY; Kim JH; Lee JH; Kim YH; Cha HJ; Kim SW; Paek SH; Shin CS
    Endocr J; 2018 Jan; 65(1):33-41. PubMed ID: 28931779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current and future therapy of acromegaly].
    Hána V
    Vnitr Lek; 2016; 62(9 Suppl 3):68-72. PubMed ID: 27734694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
    Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
    J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of Patients With GH Disorders May Vary According to the IGF-I Assay.
    Mavromati M; Kuhn E; Agostini H; Brailly-Tabard S; Massart C; Piketty ML; Arnoux A; Young J; Souberbielle JC; Chanson P
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2844-2852. PubMed ID: 28505364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.